The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Angiotensin II Receptor Blockade Administered after Injury Improves Muscle Regeneration and Decreases Fibrosis in Normal Skeletal Muscle
Abstract
Background: Several therapeutic agents have been shown to inhibit fibrosis and improve regeneration after injury in skeletal muscle by antagonizing transforming growth factor-β1. Angiotensin receptor blockers have been shown to have a similar effect on transforming growth factor-β1 in a variety of tissues. Hypothesis: Systemic treatment of animals after injury of skeletal muscle with an angiotensin receptor blocker may decrease fibrosis and improve regeneration, mainly through transforming growth factor-β1 blockade, and can be used to improve skeletal muscle healing after injury. Study Design: Controlled laboratory study. Methods: Forty mice underwent bilateral partial gastrocnemius lacerations. Mice were assigned randomly to a control group (tap water), a low-dose angiotensin receptor blocker group (losartan, 0.05 mg/mL), or a high-dose angiotensin receptor blocker group (0.5 mg/mL). The medication was dissolved in tap water and administered enterally. Mice were sacrificed 3 or 5 weeks after injury, and the lacerated muscles were examined histologically for muscle regeneration and fibrosis. Results: Compared with control mice at 3 and 5 weeks, angiotensin receptor blocker-treated mice exhibited a histologic dose-dependent improvement in muscle regeneration and a measurable reduction in fibrous tissue formation within the area of injury. Conclusion: By modulating the response to local and systemic angiotensin II, angiotensin receptor blocker therapy significantly reduced fibrosis and led to an increase in the number of regenerating myofibers in acutely injured skeletal muscle. The clinical implications for this application of angiotensin receptor blockers are potentially far-reaching and include not only sports- and military-related injuries, but also diseases such as the muscular dystrophies and trauma- and surgery-related injury. Clinical Relevance: Angiotensin receptor blockers may provide a safe, clinically available treatment for improving healing after skeletal muscle injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folland, J., Leach, B., Little, T., Hawker, K., Myerson, S., Montgomery, H., & Jones, D. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.02057.x · Cited by 208
Cited by
Aberrant repair and fibrosis development in skeletal muscle
Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L., & Muñoz-Cánoves, P. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-21 · Cited by 853
“Reduced tissue fibrosis after injury was also detected in mice treated with both decorin- and angiotensin receptor antagonists, with decorin also preventing TGFb-induced differentiation of myogenic cells into fibrotic cells [80].”
BackgroundSarcopenia in chronic kidney disease: what have we learned so far?
Sabatino, A., Cuppari, L., Stenvinkel, P., Lindholm, B., & Avesani, C. M. (2021) · Journal of Nephrology · doi:10.1007/s40620-020-00840-y · Cited by 507
Sports Medicine Applications of Platelet Rich Plasma
Mishra, A., Harmon, K., Woodall, J., & Vieira, A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800624283 · Cited by 397
Skeletal muscle fibrosis: an overview
Mahdy, M. A. A. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-2955-2 · Cited by 363
Uraemic sarcopenia: aetiology and implications
Fahal, I. H. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft070 · Cited by 357
Metadata
- Authors
- Bedair, H. S., Karthikeyan, T., Quintero, A., Li, Y., & Huard, J.
- Venue
- The American Journal of Sports Medicine
- Publisher
- SAGE Publications
- Published
- 2008-06-11
- Volume
- 36
- Issue
- 8
- Pages
- 1548-1554
- ISSN
- 0363-5465 (ISSN-L)
- 1552-3365
- OpenAlex
- W2128291192
- Cited by
- 199
- References
- 1
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin II Receptor Blockade Administered after Injury Improves Muscle Regeneration and Decreases Fibrosis in Normal Skeletal Muscle. https://app.cochat.ai/papers/10.1177/0363546508315470
- The paper
- Bedair, H. S., Karthikeyan, T., Quintero, A., Li, Y., & Huard, J. (2008). Angiotensin II Receptor Blockade Administered after Injury Improves Muscle Regeneration and Decreases Fibrosis in Normal Skeletal Muscle. The American Journal of Sports Medicine. https://doi.org/10.1177/0363546508315470
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.